Form 4: Hims & Hers Chief Legal Officer Files Form 4 for Future Stock Sale Under 10b5-1 Plan

Hims & Hers Health, Inc.'s Chief Legal Officer, Soleil Boughton, has filed a Form 4 disclosing a pre-scheduled sale of 2,572 shares of Class A Common Stock on June 30, 2025, pursuant to a Rule 10b5-1 trading plan.

Summary

• Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc. (HIMS), is the reporting person for this transaction.
• The filing reports a planned disposition (sale) of 2,572 shares of Class A Common Stock.
• The transaction is scheduled to occur on June 30, 2025.
• The shares are to be sold at a price of $50.5 per share.
• Following this transaction, Soleil Boughton will beneficially own 160,737 shares of Class A Common Stock.
• The sale is being executed pursuant to a Rule 10b5-1 trading plan, which was adopted on August 28, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, the fact that it's pre-planned under a 10b5-1 plan for a relatively small portion of holdings suggests it's for personal financial management rather than a negative signal about the company's prospects.

Positives

• The sale is conducted under a Rule 10b5-1 trading plan, indicating it was pre-scheduled and not based on immediate, non-public information, which mitigates concerns about opportunistic insider selling.

Negatives

• An insider, specifically the Chief Legal Officer, is selling shares, which reduces their direct equity stake in the company.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but generally neutral given the pre-planned nature of the sale under a 10b5-1 plan.

Key Dates

Recommendation

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Soleil Boughton, Chief Legal Officer